Slingshot members are tracking this event:
Axsome Therapeutics Announces Issuance of U.S. Patent Covering AXS-02 for the Treatment of Bone Marrow Lesions of the Knee; Provides Patent Protection into 2033
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|AXSM||Community voting in process|
Slingshot Insights Explained
Jan 27, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Patent, Axs-02, Bone Marrow Lesions Of The Knee